LUNG-CARCINOMA IN 1,336 PATIENTS

被引:19
|
作者
SRIDHAR, KS
RAUB, W
DUNCAN, RC
HILSENBECK, S
RICHMAN, SP
机构
[1] VET ADM MED CTR, MIAMI, FL 33125 USA
[2] JACKSON MEM HOSP, MIAMI, FL 33136 USA
[3] UNIV MIAMI, SCH MED, DEPT MED, MIAMI, FL 33101 USA
[4] UNIV MIAMI, SCH MED, SYLVESTER COMPREHENS CANC CTR, MIAMI, FL 33101 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1991年 / 14卷 / 06期
关键词
LUNG CARCINOMA; SURVIVAL RATES;
D O I
10.1097/00000421-199112000-00008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Characteristics of 1336 successive lung cancer patients diagnosed between 1977 and 1986 according to the Tumor Registry of the University of Miami and Jackson Memorial Hospitals were 92% smokers, 69% men, and 68% white. The histologic subtypes were 32% squamous cell carcinoma, 26% adenocarcinoma, 19% small-cell carcinoma, 12% large-cell carcinoma, 8% adenosquamous carcinoma, and 3% bronchiolaveolar carcinoma. Age distribution was as follows: younger than 45, 8%; 45-54, 21%; 55-64, 36%; 65-74, 25%; and 75 years or older, 10%. Local stage constituted 15%; regional, 26%; and distant 60%. Women had a higher number of nonsmokers and adenocarcinoma. Black patients presented with lung carcinoma at a younger age than white patients. Younger patients and black patients presented with more advanced stages than older patients and white patients. The significant factors predictive of better survival were local stage and white race. Patients with bronchioloalveolar carcinoma had a better survival rate (p < 0.02) than the other histologic subtypes, probably because of a higher incidence of local stage. There were no differences in survival between the other histologic subtypes. There were significant increases in adenocarcinoma (p < 0.01) and adenosquamous histologies (p < 0.025) and in distant stage (p < 0.0001); but there were no significant changes in the age and sex distribution, smoking history, and survival rate at our center over the 10-year study period.
引用
收藏
页码:496 / 508
页数:13
相关论文
共 50 条
  • [1] ANTIPERINUCLEAR ACTIVITY IN LUNG-CARCINOMA PATIENTS
    YOUINOU, P
    ZABBE, C
    EVEILLAUD, C
    DEWITTE, JD
    KERBOURCH, JF
    FEREC, C
    CLAVIER, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1984, 18 (02) : 80 - 81
  • [2] SCINTIGRAPHIC EVALUATION OF PATIENTS WITH LUNG-CARCINOMA
    ALDERSON, PO
    CHEST, 1986, 89 (04) : S245 - S248
  • [3] URINARY HEXOSAMINIDASE IN PATIENTS WITH LUNG-CARCINOMA
    BRATTAIN, MG
    KIMBALL, PM
    DURANT, JR
    PRETLOW, TG
    SMITH, D
    CARPENTER, J
    MARKS, M
    CANCER, 1979, 44 (06) : 2267 - 2272
  • [4] THE INFLUENCE OF PLASMAPHERESIS ON HEMOSTASIS IN PATIENTS WITH LUNG-CARCINOMA
    TARABYKIN, AA
    KLYACHKIN, BM
    BASARGIN, ST
    TERAPEVTICHESKII ARKHIV, 1990, 62 (09) : 108 - 111
  • [5] LYMPHOCYTE NUCLEOLAR COEFFICIENT IN LUNG-CARCINOMA PATIENTS
    BAKARDJIEV, GT
    DASKALOV, AN
    DOKLADI NA BOLGARSKATA AKADEMIYA NA NAUKITE, 1985, 38 (10): : 1419 - 1422
  • [6] SURGERY FOR LUNG-CARCINOMA IN PATIENTS WITH PREOPERATIVE IRRADIATION
    DOBROVOLSKY, SR
    GRIGORYEVA, SP
    IVANOV, AN
    FISHKOVA, ZP
    KHIRURGIYA, 1994, (06): : 13 - 17
  • [7] THYMUS FUNCTION IN PATIENTS WITH RESECTABLE LUNG-CARCINOMA
    ISRAEL, L
    HAJJI, F
    RIGAUT, JP
    AMOUROUX, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1984, 18 (01) : 24 - 28
  • [8] IMMUNOSCINTIGRAPHY OF LUNG-CARCINOMA - EXPERIENCE IN 45 PATIENTS
    RIVA, P
    PAGANELLI, G
    RICIPUTI, G
    PASINI, G
    BENINI, S
    AGOSTINI, M
    MOSCATELLI, G
    CACCIAGUERRA, G
    TISON, V
    MORIGI, P
    STANCANELLI, V
    BRITISH JOURNAL OF CANCER, 1986, 54 (03) : 538 - 538
  • [9] Estimating the prevalence of pathogenic germline variants in cancer susceptibility genes in 1,336 cases of renal cell carcinoma
    Yngvadottir, Bryndis
    Andreou, Avgi
    Bassaganyas, Laia
    Larionov, Alexey
    Cornish, Alex J.
    Chubb, Daniel
    Saunders, Charlie N.
    Smith, Philip
    Zhang, Huairen
    Cole, Yasemin
    Larkin, James
    Browning, Lisa
    Turajlic, Samra
    Litchfield, Kevin
    Houlston, Richard S.
    Maher, Eamonn R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 10 - 11
  • [10] GLYCOSAMINOGLYCANS IN LUNG-CARCINOMA
    KAWAI, T
    SUZUKI, M
    KAGEYAMA, K
    HUMAN PATHOLOGY, 1988, 19 (11) : 1288 - 1292